| abstract |
Topical ophthalmic composition comprising an effective antimicrobial amount of Moxifloxacin or a pharmaceutically acceptable hydrate or salt thereof, in a concentration of 0.1 to 1.0% by weight and a pharmaceutically acceptable carrier for it, for use in treatment or prevention of an ophthalmic infection. which is conjunctivitis, in which the treatment or prevention of ophthalmic infection comprises the topical application of one to four drops of a sterile solution or suspension of said topical ophthalmic composition, one to four times per day, to the affected ophthalmic tissue. |